Day: May 22, 2025

BROOKINGS, S.D., May 22, 2025 (GLOBE NEWSWIRE) — Daktronics, Inc. (Nasdaq: DAKT), a leading global designer and manufacturer of best-in-class dynamic video communication displays and control systems for customers worldwide today announced that Brad Wiemann, Interim Chief Executive Officer and Howard Atkins, Acting Chief Financial Officer will participate in the Craig-Hallum Capital Group’s 22nd Annual Institutional Investor Conference to be held Wednesday, May 28th, 2025 in Minneapolis, MN. ABOUT DAKTRONICSDaktronics has strong leadership positions in, and is the world’s largest supplier of, large-screen video displays, electronic scoreboards, LED text and graphics displays, and related control systems. The Company excels in the control of display systems, including those that require integration of multiple complex displays...

CAMBRIDGE, Mass. and TOKYO, Japan and PRINCETON, N.J., May 22, 2025 (GLOBE NEWSWIRE) — Cullinan Therapeutics, Inc. (Nasdaq: CGEM), Taiho Pharmaceutical Co., Ltd., and Taiho Oncology, Inc. today announced new positive results from the pivotal Phase 2b cohorts of the REZILIENT1 trial, a Phase 1/2 clinical trial of zipalertinib monotherapy in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutations (ex20ins) who have received prior therapy. These data will be presented on Sunday, June 1 at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting as an oral presentation during the “Lung Cancer – Non-Small Cell Metastatic” session from 9:00 AM-9:12 AM CDT (Abstract #8503). “People living with EGFR ex20ins NSCLC urgently need well-tolerated...

ROHM’s Expanded Portfolio of Surface-Mount Near-Infrared (NIR) LEDsOptimized for applications such as VR/AR devices, industrial optical sensors, and human detection sensorsRadiant Intensity Comparison of ROHM’s New SML-P14RW vs Standard NIR LEDAchieving approximately 1.4 times the radiant intensity at the same current valueSanta Clara, CA and Kyoto, Japan, May 22, 2025 (GLOBE NEWSWIRE) — ROHM Semiconductor today announced an expanded portfolio of surface-mount near-infrared (NIR) LEDs with new compact top-view types optimized for applications such as VR/AR devices, industrial optical sensors, and human detection sensors. The demand for advanced sensing technologies utilizing near-infrared (NIR) has grown in recent years, particularly in VR/AR equipment and biosensing devices. These technologies are...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® infusion New data at ASCO from the CARTITUDE-4 study to showcase improved progression-free survival and overall survival with CARVYKTI® versus standard of care (SOC) in key subgroups Preliminary results from ongoing Phase 1 dose-escalation studies of LB2102 in lung cancers and LB1908 in gastroesophageal cancers to be featured in poster presentations at ASCO Data on LB2102 was also recently presented at the ASGCT Annual MeetingSOMERSET, N.J., May 22, 2025 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new data evaluating CARVYKTI® (ciltacabtagene...

Menlo Park, CA, May 22, 2025 (GLOBE NEWSWIRE) — Cal Redwood Acquisition Corp. (the “Company”) announced the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit on May 22, 2025. The units are expected to be listed for trading on the Nasdaq Global Market under the ticker symbol “CRAQU” beginning May 23, 2025. Each unit consists of one Class A ordinary share and one right to receive one tenth of a Class A ordinary share upon the consummation of an initial business combination. Once the securities comprising the units begin separate trading, the Company expects that its Class A ordinary shares and rights will be listed on the Nasdaq Global Market under the symbols “CRA” and “CRAQR,” respectively. The offering is expected to close on May 27, 2025, subject to customary closing conditions. The Company...

Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) — Onconetix, Inc. (Nasdaq: ONCO) (the “Company”) announced that it received a Staff delisting letter from The Nasdaq Capital Market (“Nasdaq”) on May 20, 2025 indicating that the Company’s failure to file its Quarterly Report on Form 10-Q for the three months ended March 31, 2025 (the “10-Q”) is in violation of Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”). This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification. As previously reported in the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “Commission”) on April 24, 2025, the Company received a deficiency notice from Nasdaq that the Company was not in compliance with...

– Renowned neuroscience drug developer joins to support strategic development of long-acting CNS therapeutics – HUNTSVILLE, AL, May 22, 2025 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing a pipeline of product candidates leveraging its proprietary POZ Platform™ drug optimization technology, today announced the appointment of Stephen (Steve) Brannan, M.D., to its Board of Directors. Dr. Brannan brings more than three decades of experience in neuroscience and neuropsychiatry drug development, with a proven track record of leading clinical programs from early development through regulatory approval and commercialization. Most recently, he served as Chief Medical Officer at Karuna Therapeutics, where he led the clinical strategy for KarXT...

LITTLE ROCK, Ark., May 22, 2025 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced today that its Senior Vice President, Chief Financial Officer and Treasurer, Paul Bullington, and Senior Vice President, Investor Relations & Treasury, Bill DiTullio, are scheduled to participate at the Goldman Sachs 10th Annual Leveraged Finance and Credit Conference on May 29, 2025 in Dana Point, CA. Any investor materials will be made available on Uniti’s Investor Relations website at investor.uniti.com under the Events & Presentations tab. ABOUT UNITI Uniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of fiber and other wireless solutions for the communications industry. As of March...